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ABSTRACT: Catanionic surfactant mixtures form a wide variety of organized assemblies and 
aggregates with improved physicochemical and biological properties. The green catanionic 
mixture C3(CA)2:lichenysin (molar ratio 8:2) showed antimicrobial synergies against Yersinia 
enterocolitica, Bacillus subtilis, Escherichia coli O157:H7 and Candida albicans. Flow cytometry 
and viability studies indicated that this catanionic mixture increases the probability of Y. 
enterocolitica (38.2%) and B. subtilis (17.1%) cells entering a viable but nonculturable state. Zeta 
potential showed that one of the cationic charges of C3(CA)2 is neutralised by lichenysin. An 
isotherm study demonstrated the formation of a stable aggregate between the two surfactants that 
was able to interact with bacterial phospholipids. The lowest hemolysis (22.1μM) was obtained 
with the catanionic mixture, although an irritant potential (0.70) was characterised. According to 
the therapeutic index, the C3(CA)2:lichenysin mixture was the formulation least toxic to eukaryotic 
cells. Partial neutralisation of C3(CA)2 by lichenysin modified the mode of action that enhances 
the transition of bacterial cells into a viable but nonculturable state (VBNC) and improved the cell 
selectivity. 
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INTRODUCTION 
Surface active molecules or surfactants are an extensive group of amphiphilic compounds 
bearing both a hydrophilic head group and a hydrophobic hydrocarbon chain, which allows them 
to interact at the interfaces between aqueous and non-aqueous systems, thus reducing the surface 
tension.1 The properties and efficiency of a surfactant are determined by the relative size of its 
hydrophobic and hydrophilic parts, the presence of charges, and degree of hydration. The 
hydrophobic end consists of a saturated or unsaturated alkyl chain of different lengths and 
flexibility. The hydrophilic head group can be cationic (positively charged), anionic (negatively 
charged), zwitterion (neutral with charges), or non-ionic (without charge).2 In an aqueous 
environment, when surfactants saturate the interface, they form aggregates called micelles, which 
minimize the free energy of the solution. The lowest saturation concentration is known as the 
critical micellar concentration (CMC).1,2 
Surfactants are used for their surface activity as ingredients of many formulations, including 
household detergents and personal care products, and have extensive usage in the pharmaceutical, 
petrochemical and mining industries. They also have potential applications in hi-tech fields such 
as nanotechnology and molecular biology. Additionally, many studies have reported antimicrobial 
activity of cationic surfactants. Considering the global problem of antibiotic resistance, this opens 
the possibility of using surfactants to reduce antibiotic or preservative consumption, even though 
their antimicrobial properties are far from the level of antibiotics. A combination of surface and 
antimicrobial activity is also very interesting for industrial applications. Current research is seeking 
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new surface active molecules to obtain novel surfactants that are more effective, environmentally 
friendly and with enhanced antimicrobial activity.3-5 
Amino acid-based surfactants are added-value products with a hydrophilic moiety based on one 
or more amino acids from enzymatic synthesis or protein hydrolysis, and a hydrophobic moiety 
obtained from natural oils. Their synthesis and properties meet most of the principles of Green 
Chemistry: prevention of waste, atom economy, the use of less hazardous chemicals, safe 
materials, and renewable feedstocks, catalysis and design of degradable products. They are a 
promising alternative to conventional synthetic surfactants due to their enhanced surface activity, 
antimicrobial properties, biodegradability and sustainable production.5 
Biosurfactants produced by microorganisms are sustainable products that could replace chemical 
synthesis-based surfactants. Among them, lipopeptides are produced by various bacteria and are 
composed of a β-hydroxyl fatty chain bound to a cyclic polypeptide.6 Lichenysin is a cyclic 
lipopeptide similar to surfactin synthesized by Bacillus licheniformis.7 Coronel-León et al.8 
characterised the isoforms of lichenysin (Figure 1A) produced by B. licheniformis AL1.1, isolated 
from Antarctic soil samples.9 LichenysinAL1.1 has a cyclic peptide bearing seven amino acids as a 
large polar head, including an anionic residue of L-Asp, and a β-hydroxyl fatty chain of 14 carbons, 
although chains of 15 and 16 carbons were also found. Thus, it is a surface-active molecule with a 
negative charge and a mean molecular weight of 1043 g/mol, which reduces the surface tension of 
water to 28.5 mN/m at the CMC of 14.4 μM. 
Typically, mixtures of anionic and cationic surfactants in aqueous solutions contain catanionic 
vesicles. These aggregates have attracted attention due to their morphological similarity with 
classical liposomes, over which they have several advantages: they can be prepared using 
inexpensive materials and without the input of mechanical energy, and the resulting formulations 
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are thermodynamically stable for long periods of time.10 Recently it has been demonstrated that 
catanionic mixtures may also have improved biological properties, attributed to synergistic effects, 
compared with those of the individual components.11 
In a previous study, the catanionic mixture of lichenysin and an arginine-based surfactant 
showed synergistic antimicrobial activity.12 These results prompted us to explore new catanionic 
mixtures (lichenysin plus arginine-based surfactants) in order to define the molecular requirements 
in their chemical structures for synergistic antimicrobial activity, and to characterise their mode of 
action and physicochemical and physiological properties. 
EXPERIMENTAL SECTION 
Materials. NαNω-bis(Nαcaproylarginine) α, ω-propyldiamide (C3(CA)2) (Figure 1B) and N
α-
caproyl-arginine methyl ester (CAM) (Figure 1C) are arginine-based surfactants. CAM is a single-
chain surfactant with 10 atoms in the fatty chain, while C3(CA)2 is a gemini surfactant arising from 
the dimerization of two molecules of CAM, connected by a spacer chain of 3 carbon atoms.13,14 
C3(CA)2 and CAM have molecular weights of 766.5 and 378 g/mol, and reduce the surface tension 
of water to 32 and 40 mN/m at CMCs of 4.3 and 16 mM, respectively. 
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Figure 1. Chemical structures of lichenysin (A), C3(CA)2 (B) and CAM (C). 
Microorganisms and culture conditions. Lichenysin was produced by B. licheniformis AL 1.1 
in cultures of up to 100 mL of mineral medium (MM) (glucose 10 g/L, KH2PO4 4 g/L, Na2HPO4 
5.7 g/L, (NH4)2HPO4 6.6 g/L, FeSO4·4H2O 0.01 g/L, MgSO4·7H2O 0.21 g/L, CaCl2 7·10
-6 g/L 
and oligo-elements solution, 0.05 mL/L: H3BO3 0.148 g, CuSO4·5H2O 0.196 g, MnSO4·H2O 0.154 
g, Na2MoO4·2H2O 0.15 g and ZnSO4·7H2O 0.307 g in 100 mL of oligo-elements solution) in 
baffled flasks, adapted from Coronel-León et al.8 The inoculum was a suspension equivalent to 
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McFarland standard n.4 of B. licheniformis AL1.1 prepared in Ringer’s solution (Scharlau Chemie, 
Spain) from overnight colonies grown on TSA plates (Conda Pronadisa, Spain). It was inoculated 
in a final concentration of 2% (v/v) and incubated for 72 hours at 30ºC in agitation at 120 rpm. 
Strains used to test the antimicrobial activity were Escherichia coli ATCC 25922, Escherichia 
coli O157:H7 CECT 4267, Pseudomonas aeruginosa ATCC 27853, Klebsiella pneumoniae ATCC 
13883, Yersinia enterocolitica ATCC 9610, Staphylococcus aureus ATCC 29213, Staphylococcus 
aureus methicillin-resistant (MRSA) ATCC 43300, Staphylococcus epidermis ATCC 12228, 
Bacillus subtilis ATCC 6633, Listeria monocytogenes ATCC 15313, Kocuria rhizophila ATCC 
9341 and Candida albicans ATCC 10231. 
Lichenysin recovery. After 72 hours, the culture on MM was centrifuged (9000 rpm for 20 min 
at 4ºC) and the supernatant was lyophilised (Cryodos from Telstar) until complete dryness. Three 
consecutive organic liquid/liquid extractions with ethyl acetate:methanol 8:1 (V:V) were 
performed from the lyophilization product solubilized in up to 5 ml of water. The organic phase 
was filtered with Whatman n.1 filter paper. The solvent was evaporated in vacuum and the organic 
extract was recovered in the desired solvent or dried. 
Surface tension (γ) measurement. The ring technique was used to estimate the surface tension 
of culture supernatants with a Tensiometer K9 (Krüss, Germany). The instrument was calibrated 
against ultrapure water (γST=72.3 mN/m) and pure ethanol (γST=22.7 mN/m). Measurements were 
performed in triplicate at a constant temperature (25ºC). 
Zeta-potential. Lichenysin, C3(CA)2, CAM and mixtures of C3(CA)2:lichenysin, 5:5 and 8:2 
(mol:mol), and CAM:lichenysin, 5:5 and 8:2 (mol:mol), were prepared in concentrations of 0.5 
mM in miliQ water. The zeta-potential of the aggregates was obtained by analyzing the samples 
in a Zetasizer Malvern Nano-ZS using a ZeNO112 cell. The value was taken as the mean of three 
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independent measurements. Each measurement was in turn the average of ten sub-measurements 
of 20 s each. 
Monolayer isotherms. Monolayer isotherms (surface pressure versus mean molecular area, π-
A) at 37ºC were measured using a Langmuir balance (KSV Instruments Minitrough, Finland) and 
a paper Wilhelmy plate (Whatman ashless) as detailed in Lozano et al.15 The surface pressure is 
defined as π=γ0-γ, where γ0 is the water surface tension (72.3 mN/m). Tris buffer 20 mM (Merck, 
Germany) at pH 6.8 was used as the subphase. Monolayers of lichenysin, C3(CA)2, CAM and an 
E. coli total lipid extract (TLE) (Avanti Polar Lipids, USA) were studied. Weight composition and 
charges at pH 6.8 of the TLE were phosphatidylethanolamine 57.5% (zwitterionic), 
phosphatidylglycerol 15.1% (one negative charge), cardiolipin 9.8% (two negative charges) and 
an unknown fraction 17.6%. The mean molecular weight was estimated as 772.75 g/mol from the 
phospholipid fraction. Aliquots of 25 µL of single components, catanionic mixtures of 
surfactants:lichenysin (molar ratio 8:2) and mixtures with TLE (volume ratio 8:2), all prepared in 
chloroform:ethanol 9:1 (V:V) at 1 mg/mL, were spread on the surface with a microsyringe 
(Hamilton 50±1 µL). The subphase was agitated with a stirrer and evaporation of the solvent was 
allowed for 15 min. The rate of symmetric compression was 20 mm/min. The surface pressure was 
monitored by the plate’s weight. Each isotherm was measured at least twice. The π-A curve was 
plotted using the statistical software OriginPro 8. Mixed isotherms were analyzed as binary 
mixtures of monolayers. The excess of free energy of the mixture (ΔGm
ex) was calculated 
considering ΔGm
ex =0
π(A12-x1*A1-x2*A2)dπ where A12 is the mean molecular area of the binary 
mixture, x1 and x2 are the molar fractions of the components in the mixture and A1 and A2 are the 
respective molecular area of each component in a pure monolayer.16 Integrations were performed 
from inverted π-A curves using OriginPro 8. 
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Minimal inhibitory concentration (MIC) determination. MIC was determined for lichenysin, 
C3(CA)2, CAM, and their mixtures at a molar ratio of 8:2 (surfactant:lichenysin) as detailed in 
Coronel-León et al.12 Suspensions in Ringer’s solution from overnight cultures on TSA of the 
corresponding microorganism, L. monocytogenes cultured on Brain-heart infusion agar 
(ThermoFisher scientific, England), were used as the inoculum. Cell concentrations were 
estimated spectrophotometrically to obtain a final cell concentration in the well of 5·105 cfu/mL 
of the tested bacteria, or 2.5·103 cfu/mL of C. albicans. Plates were incubated for 16-20 h at 37ºC 
for bacteria and 46-50h for C. albicans. Synergy between the products was determined using the 
fractional inhibitory concentration (FIC) that is defined as: 
FIC=(a*MICm/MICa)+(b*MICm/MICb), where a and b are the percentages of surfactant and 
lichenysin in the mixture, respectively, MICm is the MIC of the mixture, and MICa and MICb are 
the MICs of the surfactant and the lichenysin, respectively. Synergy was considered present only 
when FIC values were below 0.5.17 
Exposure of microorganisms to surfactants. The inoculum was prepared as in the MIC 
determination. Contacts between microorganisms (E. coli O157:H7, Y. enterocolitica, B. subtilis 
and C. albicans) and products (C3(CA)2 and C3(CA)2:lichenysin 8:2 (mol:mol)) took place in 
buffered peptone water (BPW) (ThermoFisher scientific, England), supplemented with MIC 
values of the products and 10% (V/V) of inoculum: 107 cfu/mL for bacteria and 2·105 cfu/mL for 
C. albicans, and incubated at room temperature. 
Viability assay. At time 0 and every 30 minutes, 1 mL of sample was taken and immediately 
diluted 1/10 in Ringer’s solution to stop the effect of the product. A cell count was performed for 
each sample by preparing serial dilutions, inoculating TSA plates with 100 µL inoculum and 
incubating for 16h at 37ºC. 
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Flow cytometry (FC). Negative and positive controls were performed in parallel, with 
incubations without products and with heat treatment (70ºC), respectively. At 150 min for Y. 
enterocolitica, 105 min for B. subtilis and 90 min for E. coli O157:H7 and C. albicans, 10 mL of 
the samples were taken and centrifuged (9000 rpm for 20 min at 4ºC). The pellet was suspended 
in 2 mL of BPW and diluted 1/100 in filtered PBS (pH 7.4) at a final volume of 500 μL. In parallel, 
a cell count was performed. All the samples were stained with 1 µL of bis-oxonol (BOX) (250 µM 
in ethanol), and 5 µL of propidium iodide (PI) (1 mg/mL in water), and incubated for 5 min at 
room temperature. 200 µL to 500 µL of sample were loaded in the FC Cytomics FC500NPL 
(Beckman Coulter, USA). Fluorescence from BOX (560 nm) and PI (617 nm) was detected. 
Transmission electronic microscopy (TEM). Negative controls were performed in parallel 
with incubations without products. At the same times as the FC assay, all the suspension volume 
was centrifuged at 9000 rpm for 20 min at 4ºC. The pellet was resuspended in 1 mL of BPW and 
centrifuged again at 10000 rpm for 10 minutes. The pellet was fixed with glutaraldehyde 2.5% 
with 0.1M phosphate buffer (PB) at 4ºC for 2 hours. Samples were centrifuged (2500 rpm for 10 
minutes), washed four times with 0.1M PB (4ºC) and fixed with 0.1M PB with 1% of OsO4 and 
0.8% of K4[Fe(CN)6] (4ºC for 2 hours in darkness). Four washes were performed with miliQ water 
and then by 0.1M PB. The sample was dehydrated at 4ºC with sequential concentrated acetone: 
50, 70, 90 and 96% (10 minutes), and 100% (15 minutes). Thereafter, samples were infiltrated, 
polymerized, sectioned and mounted as reported in Colomer et al.18 Ultrathin sections were 
observed in a JEOL 1010 microscope (EM). 80Kv images were acquired using a CCD Megaview 
1kx1k. 
Red blood cell (RBC) assay and therapeutic index. Hemolytic activity, denaturation of 
hemoglobin and irritancy potential of the corresponding concentration ranges of lichenysin (1-15 
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μM), C3(CA)2 (5-40 μM) and C3(CA)2:lichenysin 8:2 (mol:mol) (9-23 μM) were determined using 
a protocol adapted from Pape and Hoppe.19 A rabbit blood sample, supplied by the Animal 
Experimentation Unit (Centres Científics I Tecnològis de la UB, CCiTUB), was cleaned thrice 
with Hepes buffer (150mM NaCl, 5mM Hepes, pH 7.4) on ice and diluted until reaching 
Abs540nm=1. Eight dilutions below the CMC of pure surfactants and the catanionic mixture were 
prepared, concentrated 20-fold. 10 μL of the concentrated samples were added to 200 μL of 
erythrocyte solution (in triplicate), incubated for 20 min at 37ºC and centrifuged at 3000rpm for 4 
minutes (AllegraTM 25R, Beckman Coulter). Supernatants were collected and analyzed by a 
spectrophotometer at 540 and 575 nm (Sinergy HT microplate reader, Biotek). The extent of 
hemolysis was determined by the relative proportion of absorbance at 540 nm of each sample 
against a completely hemolyzed control (erythrocyte solution with distilled water in the same 
conditions). The concentration at which hemolysis (H50) occurred in 50% of red blood cells (RBC) 
was calculated from concentration-hemolysis curves. The denaturation index (DI) was calculated 
as DI=[(R1-Ri)/(R1-R2)]*100, where R1 is 1.05, the constant ratio Abs575/Abs540 of oxyhemoglobin, 
R2 is the ratio Abs575/Abs540 of the hemolysis of 100 mg/mL of SDS, and Ri is the ratio 
Abs575/Abs540 of the samples. Irritancy potential was calculated as the H50 [μg/mL] / DI [%] 
quotient from the results after 20 minutes of incubation. A physiological correlation can be 
determined using the following scale: non-irritant (>100), slightly irritant (>10), moderately 
irritant (>1), irritant (>0.1) and very irritant (<0.1).19 Relative selectivity for each microorganism 
strain against eukaryotic cells corresponding to the three surfactant formulations tested was 
calculated using the therapeutic index (TI), defined as the H50/MIC quotient. The larger the TI is, 
the more selective against microorganisms, and so less toxic against eukaryotic cells.4 
RESULTS AND DISCUSSION 
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Production, extraction and characterization of lichenysin. Lichenysin was produced in the 
culture supernatant, which after 72 hours of incubation had a surface tension of 30±2 mN/m. 
Lichenysin was recovered using the lyophilization-based concentration method, with a final 
productivity of crude extract up to 351.5 mg/L. The organic extract and purified lichenysin were 
compared by TLC to check purity. From here onwards the organic extract will be referred to as 
lichenysin. 
Zeta potential. The zeta potential of C3(CA)2, CAM, lichenysin and its binary mixtures was 
measured to study how the surfactants interact in catanionic mixtures. The zeta potential of 
C3(CA)2 and CAM was 60 and 30 mV, respectively, while that of lichenysin was -30 mV. These 
values correspond to the known charge of each surfactant: two positive charges of C3(CA)2, one 
positive charge of CAM and one negative charge of lichenysin. When C3(CA)2 was mixed with 
lichenysin at a molar ratio of 5:5, the charge was neutralized to 38.1 mV, while the mixture 
CAM:lichenysin at the same molar ratio was neutralized to -2.8 mV, almost zero. This indicates 
that one positive charge of the surfactants interacted with one negative charge of lichenysin. The 
overall zeta potential of the mixtures of C3(CA)2 and CAM with lichenysin at 8:2 (mol:mol) 
presented a proportional neutralisation of the charge: 45.5 mV for C3(CA)2 and 26.8 mV for CAM. 
Isotherms (π-A) of mixed monolayers. Understanding the behavior of mixed monolayers is of 
great interest because it provides insight into the interactions between the monolayer compounds 
and contributes to a general study model for biological systems. To study the interaction of 
lichenysin with the arginine-based surfactants, a simple monolayer membrane model was used. 
The aim of these experiments was to figure out the mechanism of the surfactant interaction with 
bacterial membranes. Thus, the behavior of monolayers of mixtures of lichenysin with C3(CA)2 
and CAM, as well as the effect of these mixtures against a monolayer of a total lipid extract from 
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E. coli (TLE), was studied. The TLE, rich in phosphatidylethanolamine and phosphatidylglycerol, 
was used as a simplified model of an Enterobacteriaceae membrane. 
The π-A isotherms of mixed monolayers at 37ºC with C3(CA)2 are shown in Figure 2A. The 
C3(CA)2 isotherm is not shown because the gemini surfactant is partially soluble and on 
compression dissolves in the subphase. The lichenysin isotherm shows a profile with a starting 
gaseous phase and an expanded liquid phase until monolayer collapse. On the other hand, the TLE 
isotherm has a short expanded liquid phase followed by a condensate liquid phase until collapse. 
The isotherm of the C3(CA)2:lichenysin binary mixture shows a liquid condensate and collapsed 
phases. The fact that the surface pressure (π) at collapse of C3(CA)2:lichenysin is higher than that 
of either component indicates a higher number molecules on the monolayer, which might be 
interacting to form a mixed or catanionic aggregate. Isotherms of binary systems of TLE with 
C3(CA)2 and TLE with lichenysin (Figure 2A) are almost parallel and have a lower π at collapse 
than the isotherm of TLE alone. This indicates that there are fewer molecules at the interface 
because of the formation of mixed aggregates that solubilize into the subphase. The isotherms of 
TLE and TLE:lichenysin are also included in Figure 2B for clarity. Comparing the mixed isotherm 
of the three components with the isotherm of TLE, it can be seen that they have the same profile, 
with a slight increase of the π at collapse. Given that the π of the TLE:C3(CA)2:lichenysin isotherm 
at collapse is also higher than those of the monolayers corresponding to the studied binary systems, 
TLE:lichenysin and TLE:C3(CA)2, we propose that the mixture C3(CA)2:lichenysin has a synergic 
effect, albeit slight, when mixed with TLE, which indicates that C3(CA)2 forms catanionic 
aggregates with lichenysin. 
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Figure 2. Isotherm curves, surface pressure – mean molecular area (π-A), of: (triangles) total lipid 
extract of E. coli (TLE), (empty circles) TLE:Lichenysin, (empty squares) TLE:Surfactant, 
(crosses) TLE:Surfactant:Lichenysin, (filled squares) Lichenysin 20%, (filled circles) 
Surfactant:Lichenysin 20%. Surfactants are C3(CA)2 (A) and CAM (B). 
To compare the gemini surfactant mixtures with those of a single-chain surfactant, the same 
experiments were performed with CAM, the monomeric counterpart of C3(CA)2. The π-A 
isotherms of mixed monolayers at 37ºC with CAM are shown in Figure 2B. Like C3(CA)2, CAM 
is also soluble in water and its isotherm is not shown. The binary CAM:lichenysin isotherm shows 
a short expanded liquid phase and a condensate liquid phase with a high π at collapse. Similarly to 
C3(CA)2, CAM forms catanionic aggregates with lichenysin. However, contrary to the C3(CA)2 
results, the isotherm curve of the monolayer of the three components (TLE:CAM:lichenysin) 
shows a π at collapse lower than TLE alone and lower than the isotherm of CAM:lichenysin. This 
indicates a lower number of molecules in the monolayer or that the molecules remaining in the 
monolayer have less surface activity. 
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As explained before, one molecule of the cationic surfactants C3(CA)2 or CAM interacts with 
one molecule of the anionic lichenysin. The resulting catanionic aggregates would be cationic and 
non-ionic, respectively, and in the case of C3(CA)2,  interactions with the partially negatively-
charged phospholipids of TLE would be preferred. The formation of a catanionic aggregate with 
a different charge may explain the differences in the monolayer behaviour. 
A complementary analysis of the data obtained was performed in order to understand the 
interactions and miscibility of the components by calculating the excess of free energy of the 
mixtures, ΔGm
ex. If all the components mix ideally, at a given surface pressure and temperature, 
the proportional sum of areas of single component isotherms would be equal to the experimental 
area of the mixed monolayer isotherm. Any deviation would be due to interactions between 
components and partial or total miscibility. Hence, in a binary system, an ideal behaviour without 
miscibility of any component would result in ΔGm
ex=0, while any deviation from it will be due to 
molecular interactions, even with the subphase, or the miscibility of each component or mixed 
aggregates.16 A negative value of the excess of free energy evidences strong interactions of the 
two components, which leads to a partial formation of miscible complexes or aggregations that are 
diluted in the subphase, whose quantity depends on the molar ratio of the components. On the 
other hand, a positive value of the excess free energy evidences that the interactions between the 
two components are weaker than the individual self-interactions. In this case, at least one 
component forms auto-aggregates and becomes diluted in the subphase.20 ΔGm
ex values for 
C3(CA)2, CAM and their mixtures with lichenysin and TLE are shown in Figure 3. 
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Figure 3. Excess of free energy, ΔGm
ex (J/mol), of mixtures based in C3(CA)2 (A) and CAM (B). 
Mixtures: Total lipid extract(TLE):Surfactant:Lichenysin (red), TLE:Lichenysin (yellow), 
TLE:Surfactant (green) and  Surfactant:Lichenysin (blue). 
The binary mixtures with C3(CA)2 (C3(CA)2:lichenysin and TLE:C3(CA)2) both have positive 
ΔGm
ex values, of 6016.06 and 1337.48 J/mol, respectively (Figure 3A), indicating that C3(CA)2 
forms auto-aggregates and solubilizes in the subphase. Although auto-aggregation of C3(CA)2 is 
thermodynamically more favoured, the π-A isotherm of C3(CA)2:lichenysin (Figure 2A) shows 
that part of C3(CA)2 forms stable catanionic aggregates with lichenysin that remain in the 
monolayer. Given that one molecule of lichenysin partially neutralizes a molecule of C3(CA)2 and 
the molar ratio for this binary mixture is 8:2, there would be free molecules of C3(CA)2. The auto-
aggregation of the excess of C3(CA)2 in the mixture might explain the higher ΔGm
ex value. The 
ΔGm
ex of the binary mixture TLE:lichenysin is -2494.57 J/mol. The negative value indicates the 
formation of mixed aggregates that partially solubilize in the subphase. The ΔGm
ex of the three-
component mixture is 1451.49 J/mol, indicating that the solubilization of the resulting catanionic 
mixed aggregates in the subphase is not relevant, thus the catanionic aggregate C3(CA)2:lichenysin 
is stable and remains in the phospholipid monolayer. 
Values of ΔGm
ex for CAM and its mixtures are shown in Figure 3B. The mixture with lichenysin 
has a ΔGm
ex (4460.99 J/mol) similar to that of C3(CA)2:lichenysin, and the positive value can be 
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attributed to the solubilization of the excess of CAM. The mixture with TLE has a ΔGm
ex value 
near to zero, 258.39 J/mol, which suggests that although a small part of CAM is solubilized, its 
mixture forms a very stable monolayer. Finally, the ΔGm
ex of the three-component mixture with 
CAM is negative, -771.53 J/mol, unlike the three-component mixture with C3(CA)2, which 
indicates that all or some of its components form mixed aggregates that solubilize in the subphase 
and are not present in the monolayer. In π-A isotherms (Figure 2B), this reduction of molecules in 
the monolayer corresponds to the reduction of surface pressure. 
Our hypothesis is that the mixture of TLE, C3(CA)2 and lichenysin has a synergic effect, since 
the gemini surfactant is able to remain in the phospholipid monolayer when partially neutralized 
by lichenysin. Also, the comparison with CAM suggests it might be caused by the remaining 
positive charge of the gemini surfactant, because CAM, completely neutralized by lichenysin, is 
stable when mixed with TLE but not when mixed with both TLE and lichenysin. In conclusion, 
the free cationic charge of the catanionic aggregate C3(CA)2:lichenysin allows it to become 
attached to the phospholipids of the TLE. 
Notably, the catanionic mixtures studied in this work can be considered green systems. For 
practical reasons, lichenysin was synthesized using commercial glucose as the carbon source, but 
this can be substituted by molasses. The gemini surfactant C3(CA)2 was synthesized using 
renewable raw materials, arginine and fatty acid, by a chemoenzymatic approach in which papain 
is deposited into cells.21,22 The formulations were prepared without high mechanical energy, and 
moreover, biodegradation studies showed that CAM and C3(CA)2 are readily biodegradable 
surfactants.23 
Minimal inhibitory concentration (MIC). The antimicrobial activity of lichenysin, and its 
catanionic mixtures with CAM and C3(CA)2 was determined (Table 1). As previously reported by 
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Coronel-León et al., lichenysin was not active against the microorganisms tested 
(MIC≥1000μM).24 This might be due to the null capacity of lichenysin to disrupt the cell envelope, 
which acts as a selective barrier for a wide range of solutes, perhaps because lichenysin is an 
anionic molecule, like the cell envelope itself. A successful attachment is thought to usually require 
a proper electrostatic interaction between the cell envelope and the antimicrobial molecule: 
lipopolysaccharide in the case of Gram-negative bacteria or lipoteichoc acid in Gram-positive 
bacteria.5,25 This interaction would be possible with arginine-based surfactants, which are cationic 
amphiphiles, and accordingly C3(CA)2 and CAM showed antimicrobial activity (Table 1). C3(CA)2 
was the most effective against both Gram-negative and Gram-positive bacteria and the yeast C. 
albicans. Gram-negative bacteria are usually only inhibited by relatively high concentrations of a 
cationic surfactant, since the presence of lipopolysaccharide in the outer membrane makes it more 
difficult for amphiphiles to diffuse across. Its monomeric counterpart, CAM, showed only a 
moderate antimicrobial activity against Gram-positive bacteria (Table 1). 
The MIC of the catanionic mixtures was characterized in the search for antimicrobial synergies. 
Based on previous work, a molar ratio of 8:2 was chosen.12 The fractional inhibitory concentration 
(FIC) was used to detect possible synergies in the catanionic mixtures. The only mixture that 
showed a synergy was C3(CA)2:lichenysin 8:2 (mol:mol). MICs against Y. enterocolitica, B. 
subtilis, E. coli O157:H7 and C. albicans showed FIC values of 0.1, 0.2, 0.4 and 0.4, respectively 
(Table 1). On the other hand, the mixture CAM:lichenysin 8:2 (mol:mol) did not show any synergy 
in its antimicrobial activity. The difference between the gemini and single-chain surfactants is the 
presence of two positive charges instead of one. As demonstrated, one charge of each molecule is 
neutralised by the negative charge of lichenysin and consequently, the catanionic aggregate 
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presents a synergic antimicrobial activity only if it has a cationic character after the neutralization 
by lichenysin. 
It can also be observed that formulations with the gemini surfactant were active against 
methicillin-resistant S. aureus, although a synergy was not characterized (Table 1). One of the 
major challenges to healthcare in the 21st century is the emergence of multi drug-resistant bacteria. 
Strategies to minimize this danger include an extensive education about the risks of inappropriate 
antibiotic use. Additionally, a few new antibiotics are currently in clinical development. 
Due to the promising antimicrobial behaviour of the C3(CA)2:lichenysin catanionic mixture, it 
was chosen for further studies with the microorganisms against which it had exhibited 
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Table 1. MIC values (μM) of lichenysin, C3(CA)2, the mixture C3(CA)2:lichenysin 8:2 (mol:mol), 
CAM and the mixture CAM:lichenysin 8:2 (mol:mol); FIC values of the mixtures; and therapeutic 
indices (TI) of lichenysin, C3(CA)2 and the mixture C3(CA)2:lichenysin 8:2 (mol:mol). 
Viability study by cell count and flow cytometry. To establish the time required by 
C3(CA)2:lichenysin 8:2 (mol:mol) to show significant antimicrobial activity against each 
microorganism, a viability assay was performed by incubating Y. enterocolitica, E. coli O157:H7, 
B. subtilis, and C. albicans in BPW containing the catanionic mixture at MIC values. The time 
when their viability in solid media was reduced by 90% was established as a point of reference for 
the FC and electron microscopy assays. Incubations of Y. enterocolitica, B. subtilis and C. albicans 
reached this point at 150, 105 and 90 minutes, respectively. The cell count from E. coli O157:H7 
incubation remained stable for 150 minutes, which might evidence a bacteriostatic effect. An 
arbitrary time of 90 minutes was chosen for the FC assay. 
The aim of the FC assay, using fluorescent staining reagents PI and BOX, was to determine how 
the surfactant antimicrobial activity affected the microbial cells. BOX-stained cells are associated 
with a depolarization of the cytoplasmic membrane, which is a reversible process, while PI-stained 
cells indicate pore formation and permeation of the cytoplasmic membrane, which causes cell 
death. 
No strain showed cells stained only with PI after treatments with C3(CA)2 or its mixture with 
lichenysin (Figure 4). In contrast, cells stained only with BOX, as well as with both BOX and PI, 





1000 3.9 3.9 0.8 500 >500 0,8 0.01 3.41 5.68 
C. albicans 
ATCC 10231 
>1000 15.7 7.8 0.4 500 >500 1,0 <0.01 0.85 2.84 
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C3(CA)2 and its mixture with lichenysin against cytoplasmic membranes involved a depolarization 
before permeation. This hypothesis matches the already observed unspecific mode of action of 
cationic surfactants in the disruption of the Gram-negative bacterial cell envelope: firstly 
disrupting the integrity of the outer membrane by the electrostatic interaction between the cationic 
surfactant and the anionic cell envelope, and then disintegrating the cell inner membrane through 
the hydrophobic interaction between the hydrocarbon chains of the surfactants and the bacterial 
membrane phospholipids. The subsequent cytoplasm leakage eventually leads to the death of 
bacteria.26 
 
Figure 4. Reduction of viability (Viab) and flow cytometry (FC) results of treatments with 
C3(CA)2:Lichenysin 8:2 (mol:mol) (mixture) and C3(CA)2 at the corresponding MIC and without 
treatment (control), against (A) Y. enterocolitica (150 min), (B) E. coli O157:H7 (90 min), (C) B. 
subtilis (105 min) and (D) C. albicans (90 min). Viability assay: nonculturable (red) and culturable 
(blue). Flow cytometry: BOX- and PI-stained (orange), BOX-stained (yellow), and non-stained 
 21 
(white). Areas between dotted black lines correspond to the proportion of viable but nonculturable 
cells. 
Y. enterocolitica (Figure 4A) showed a similar reduction of viability in solid media after being 
in contact with the catanionic mixture or C3(CA)2 (77.9±0.4 and 78.1±8.7%, respectively). In 
contrast, according to the FC results, the proportion of cells with a permeated and depolarized cell 
envelope was only 20.8±2.5% after treatment with the catanionic mixture, and 59.1±4.8% for the 
gemini surfactant. Interestingly, the amount of permeated cells (stained with both reagents) was 
similar after treatment with the mixture (17.2±2.5%) or C3(CA)2 (13.9±1.3%), which indicates the 
mixture is more efficient than the single surfactant, given that the MIC is reduced from 62.5 to 7.8 
μM. 
Although a high proportion of Y. enterocolitica cells were not stained, suggesting that their cell 
envelope was unaltered, they were not culturable in solid media. An explanation might be that 
other alterations, not detected by FC, rendered the cells unable to recover in solid media. Such 
cells are considered to be in a transitory viable but nonculturable (VBNC) state and represented 
57.2% of the cells treated with the mixture and 19% of those treated with C3(CA)2.
27 The VBNC 
state is associated with sub-lethal metabolic and genetic alterations in response to a stressful 
environment.28 The higher percentage of VBNC cells after treatment with the mixture indicates 
that this treatment affected the cell envelope less than the gemini surfactant, but reduced the 
viability alike. 
Results of E. coli O157:H7 (Figure 4B) differed from those of Y. enterocolitica despite both 
being Enterobacteriaceae. Almost all the cells grew on solid media, while only 13.4±19% of cells 
treated with C3(CA)2 were nonculturable. In the FC assay, 11.5±0.4 and 9±1% of cells were stained 
when incubated with the catanionic mixture or C3(CA)2, respectively, indicating an altered 
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cytoplasmic membrane. Both the reduction of viability and the FC results closely match those of 
the corresponding negative control. This strengthens the hypothesis that C3(CA)2 has a 
bacteriostatic effect against E. coli O157:H7, which is not significantly improved when mixed with 
lichenysin. 
Viability results for B. subtilis (Figure 4C) show a similar reduction after treatments with the 
catanionic mixture and C3(CA)2 (near 100%). According to the FC results, the proportion of cells 
with a permeated or depolarized membrane was low, as in Y. enterocolitica. A significant 
difference between the proportion of cells affected by the mixture (38.4±3.5%) and C3(CA)2 
(59.94±7.3%) at their corresponding MIC was also observed. The lower proportion of non-stained 
cells with respect to the nonculturable cells again indicates the presence of VBNC cells: 57.2% 
when treated with the mixture and 40.1% when treated with C3(CA)2. 
Finally, all treatments exerted a strong effect against C. albicans (Figure 4D) at 90 minutes, with 
a near 100% reduction of viability. The FC results were similar in both treatments: almost 100% 
of cells had a permeated cell envelope when treated with the catanionic mixture or the gemini 
surfactant. Thus, an interesting antifungal activity of C3(CA)2 was observed, but with such high 
values it is impossible to know if lichenysin improved the mortality effect. 
Transmission electronic microscopy (TEM). Ultrastructural alterations caused by 
C3(CA)2:lichenysin 8:2 (mol:mol) and C3(CA)2 in the most affected microorganisms, Y. 
enterocolitica, B. subtilis and C. albicans, were identified by TEM. 
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Figure 5. Transmission electronic microscopy images from (A) Y. enterocolitica (x50000), (B) B. 
subtilis (x40000) and (C) C. albicans (x20000) after 90 minutes contact with (1) 
C3(CA)2:lichenysin (7.8, 3.9 and 7.8 μM respectively) and (2) C3(CA)2 (62.5, 15.7 and 15.7 μM 
respectively). 
As shown in Figure 5A.1, most Y. enterocolitica cells incubated with the surfactant mixture had 
an intact cell envelope. Nevertheless, some cells were secreting outer membrane vesicles, and 
chromatin condensation was observed, although this has been reported as a possible artefact of the 
technique.29 When cells were treated with C3(CA)2 at its MIC (Figure 5A.2), a high amount of 
cellular waste was observed, due to cell lysis. The majority of cells showed cytoplasm 
condensation near the cytoplasmic membrane. In addition, the cell wall was clearly thinner than 
in the control (not shown). All these alterations might explain the reduction of viability (Figure 
4A) of cells treated with C3(CA)2 at its MIC. Overall, the most significant alteration of mixture-
treated Y. enterocolitica cells was the formation of outer membrane vesicles, which has been 
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recently associated with a Gram-negative bacteria stress response.30,31 These may be initial 
alterations eventually leading to the cell envelope disruption observed in C3(CA)2-treated cells, 
which received a much higher concentration of the gemini surfactant. In the FC results for Y. 
enterocolitica cells (Figure 4A), the large difference in the proportion of BOX-stained cells 
between treatments (3.5% for the mixture versus 45.3% for C3(CA)2) could be explained by the 
reduction in the cell wall width apparent in the C3(CA)2-treatment images (Figure 5A.2), with a 
consequent greater membrane depolarization in cells not yet lysated. Although the mixture caused 
less severe alterations than C3(CA)2, it is clear that both had the same impact on cell viability. 
C3(CA)2 reduced the viability by disrupting the cell envelope, while lichenysin might be acting at 
a cytoplasmic level, which would keep the cell from growing or recovering, and would explain the 
larger proportion of VBNC cells after the mixture treatment (Figure 4A). 
The effect visible in B. subtilis (Figure 5B) was milder than in Y. enterocolitica cells. Cells 
treated with the mixture or with C3(CA)2 alone showed a slight dilution of the cytoplasm. In both 
cases, empty cells were detected, but they were also observed in control images. Although the 
cytoplasm seems slightly altered, the cell wall was not broken or thinned. This could be related to 
the low proportion of cells stained only by BOX in both treatments, indicating few depolarized 
cells (Figure 4C). 
Finally, C. albicans (Figure 5C) gave interesting results. First of all, no alteration in the cell wall 
was visible, neither with the mixture nor with C3(CA)2, but the cytoplasm was severely affected. 
None of the cells presented nuclei, perhaps because they had been disrupted, or vacuoles, which 
were always present in control cells (not shown). And finally, numerous cells had begun the 
formation of one or more gems, all of which seem to have been interrupted at the same point, while 
in the control the gemmating processes had been stopped at different stages by the fixation 
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procedure. Overall, the severe alterations of the cytoplasm seem to have caused the cell death 
detected in both the viability reduction and FC assays (Figure 4D). 
The microbial cell envelope acts as an effective permeability barrier against antibiotics or 
biocides. Some compounds with little or no antimicrobial activity are being used to block or bypass 
active or intrinsic bacterial resistance mechanisms or enhance antibiotic action to rescue the 
activity of existing drugs. These compounds are called antibiotic adjuvants.32 A cationic molecule 
able to interact with a negatively charged bacterial cell envelope causing destabilization and 
permeability could allow antimicrobial compounds to enter the cell.33 According to the results 
obtained, the catanionic mixture could fulfill this role and may be considered a possible antibiotic 
adjuvant to reduce the onset of resistance. 
RBC hemolysis and therapeutic index. In order to test the irritancy potential of lichenysin, 
C3(CA)2 and their 8:2 mixture (mol:mol), the hemolysis level of these surfactants was studied. The 
resulting hemolysis curves are shown in Figure 6 and values extracted from them in Table 2. 
 
 H50 (μM) DI (%) IP 
Lichenysin 8.0 22.6 0.37 
(Irritant) 
C3(CA)2 13.3 36.9 0.28 
(Irritant) 
Mixture 22.1 25.8 0.70 
(Irritant) 
Table 2. Hemolysis (H50), denaturation index (DI) and irritant potential (IP) of lichenysin, C3(CA)2 
and their mixture at a molar ratio 8:2 (mol:mol) after 20 minutes. 
All the studied surfactant formulations were classified as irritants (Table 2). Among them, the 
mixture was the least irritant and had the highest H50 (22.1 μM), which was higher than its 
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estimated CMC (18 μM), making it the least hemolytic. Despite the low DI of lichenysin (22.6%), 
which should favour a less severe irritancy, it was also characterised as irritant. This can be 
explained by the low H50 of lichenysin (8.0 μM), resulting in a high hemolytic activity below its 
CMC (14.4 μM). Coronel-León et al. demonstrated that the presence of cholesterol in the lipid 
membrane, typical of eukaryotic cells, enhances lichenysin-induced leakage of cytoplasm.24 
Finally, C3(CA)2 had a high hemolytic activity at very low concentrations (13.3 μM), considering 
that its CMC is 4.3 mM. 
Having determined the superior antimicrobial activity of the catanionic mixture, the relationship 
between the hemolysis curves and their respective MICs against different microorganisms was key 
for establishing whether this heightened activity affects eukaryotic cells. Lichenysin showed no 
antimicrobial activity within the interval shown, so no MIC was drawn (Figure 6A). The MICs of 
C3(CA)2 (Figure 6B) and the mixture (Figure 6C) against Gram-positive bacteria were lower than 
against Gram-negative bacteria. When MIC values are compared with the hemolysis results, two 
observations stand out. First, the MICs of C3(CA)2 against Gram-negative bacteria are over the 
H50, which is the case in only a few of the MICs of the mixture. Secondly, all the MICs of the 
mixture against Gram-positive bacteria and C. albicans are below 20% of hemolysis, which is not 
achieved by the gemini surfactant. 
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Figure 6. Relationship between surfactant hemolysis and MIC. Curves: hemolysis of each 
surfactant at different concentrations after 20 minutes contact: lichenysin (A), C3(CA)2 (B) and 
C3(CA)2:lichenysin 8:2 (mol:mol) (C), in black. Corresponding MIC ranges for Gram-positive 
(G+), Gram-negative (G-) and C. albicans (Ca), in grey. 
The therapeutic index (TI) correlates MICs with the H50 to express the relative cell selectivity of 
the formulations against microorganisms (Table 1). TI values of lichenysin were the lowest, due 
to its lack of antimicrobial activity. Overall, TI values of the catanionic mixture were higher than 
those of C3(CA)2 for two possible reasons: the MICs of the mixture were lower, implying a higher 
antimicrobial activity, or the H50 was higher, resulting in less hemolytic activity. In this case, it has 
already been proven that the mixture is less hemolytic, which would improve the TI when MICs 
are equal. However, in addition, a synergic antimicrobial activity against determined strains was 
detected. Focusing on E. coli O157:H7, Y. enterocolitica, B. subtilis and C. albicans, it can be seen 
that the TIs of the mixture formulation improved at least three-fold compared to C3(CA)2. It was 
therefore more selective against microbial cells than against eukaryotic cells, while the other 
formulations were less selective. 
CONCLUSIONS 
The green catanionic mixture of C3(CA)2, a cationic arginine-based gemini surfactant, and 
lichenysin, an anionic cyclic lipopeptide biosurfactant, induces the formation of a catanionic 
aggregate with a significant synergic antimicrobial activity, in which lichenysin acts as an 
antimicrobial potentiator.  
The partial neutralisation of the two cationic polar heads of the gemini surfactant by the anionic 
charge of the biosurfactant changes its mode of action. When cells are treated with the gemini 
surfactant alone, the cell envelope is first depolarized and finally disrupted. When cells are treated 
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with the catanionic mixture, bacterial cell envelopes are not disrupted but cells are altered at a 
cytoplasmic level, which makes them more likely to enter a viable but nonculturable state. 
Additionally, the catanionic mixture showed a strong fungicidal activity. Our hypothesis is that 
the free cationic charge allows the catanionic aggregate to approach the anionic cell envelope by 
electrostatic interactions and to interact with it by aggregation with the bacterial phospholipids, 
which enhances the antimicrobial effect. On the other hand, when the cationic surfactant is 
completely neutralised, as occurs in catanionic mixtures of lichenysin and monomeric arginine-
based surfactants, no synergic antimicrobial activity is detected. Finally, the therapeutic index of 
the catanionic mixture, and thus its selectivity, is better than that of the gemini surfactant because 
it has a reduced hemolytic activity at the minimal inhibitory concentration, although it is still 
considered irritant. This study offers new insights into the potential advantages of environmentally 
friendly catanionic mixtures of green surfactants with improved surface-antimicrobial properties 
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